BI Asset Management Fondsmaeglerselskab A S Raises Stake in The Clorox Company $CLX

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

BI Asset Management Fondsmaeglerselskab A S increased its stake in The Clorox Company (NYSE:CLX - Free Report) by 295.0% during the first quarter, according to its most recent filing with the SEC. The fund owned 146,121 shares of the company's stock after buying an additional 109,127 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S owned 0.12% of Clorox worth $21,516,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the stock. Vanguard Group Inc. raised its position in Clorox by 0.4% in the first quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company's stock worth $2,293,135,000 after acquiring an additional 65,924 shares during the period. Stifel Financial Corp increased its stake in shares of Clorox by 0.4% in the fourth quarter. Stifel Financial Corp now owns 2,344,408 shares of the company's stock worth $380,761,000 after purchasing an additional 9,582 shares in the last quarter. Northern Trust Corp raised its position in shares of Clorox by 2.3% in the first quarter. Northern Trust Corp now owns 1,528,920 shares of the company's stock valued at $225,133,000 after purchasing an additional 34,655 shares during the period. Balyasny Asset Management L.P. raised its position in shares of Clorox by 28.7% in the fourth quarter. Balyasny Asset Management L.P. now owns 1,421,909 shares of the company's stock valued at $230,932,000 after purchasing an additional 316,688 shares during the period. Finally, Invesco Ltd. raised its position in shares of Clorox by 7.4% in the first quarter. Invesco Ltd. now owns 1,361,710 shares of the company's stock valued at $200,512,000 after purchasing an additional 94,371 shares during the period. Institutional investors own 78.53% of the company's stock.

Wall Street Analysts Forecast Growth

CLX has been the topic of several research reports. JPMorgan Chase & Co. lowered their price target on shares of Clorox from $144.00 to $140.00 and set a "neutral" rating on the stock in a research report on Friday, July 25th. Morgan Stanley lowered their price target on shares of Clorox from $150.00 to $137.00 and set an "equal weight" rating on the stock in a research report on Friday, August 1st. Barclays lowered their price target on shares of Clorox from $129.00 to $119.00 and set an "underweight" rating on the stock in a research report on Tuesday, July 15th. UBS Group lowered their price target on shares of Clorox from $150.00 to $134.00 and set a "neutral" rating on the stock in a research report on Thursday, July 17th. Finally, Jefferies Financial Group lowered their price target on shares of Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a research report on Thursday, June 26th. One investment analyst has rated the stock with a Buy rating, eight have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, Clorox presently has an average rating of "Reduce" and a consensus price target of $143.36.

Clorox Price Performance

Clorox stock traded up $0.3360 during midday trading on Friday, reaching $120.1760. 1,278,389 shares of the stock were exchanged, compared to its average volume of 1,919,885. The company's fifty day moving average is $124.25 and its 200-day moving average is $135.37. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The firm has a market cap of $14.70 billion, a PE ratio of 18.43, a PEG ratio of 0.96 and a beta of 0.49. The Clorox Company has a 52 week low of $117.35 and a 52 week high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. The firm had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business's revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, sell-side analysts forecast that The Clorox Company will post 7.15 EPS for the current year.

Clorox Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Wednesday, August 13th will be given a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a yield of 4.1%. The ex-dividend date of this dividend is Wednesday, August 13th. This is an increase from Clorox's previous quarterly dividend of $1.22. Clorox's dividend payout ratio is currently 76.07%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.